59:42
Living with Myositis: A Patient's Journey from Diagnosis to Management
09:02
Benefits of IVIG (IV Immunoglobulin) in Dermatomyositis
07:27
Safety of IVIG (IV Immunoglobulin) in Dermatomyositis
05:56
Kezar PRESIDIO Study Information for Myositis Patients
07:09
New Drug - Baricitinib Approved for Covid in India (Hindi)
06:45
Baricitinib in Covid 19
08:28
Guidelines on Covid Vaccine: How to manage immunosuppressive medications around Covid Vaccination.
08:27
How Covid-19 pandemic led to poor patient care?
07:56
Results of the Phase 3 Clinical Trial on IVIG in Dermatomyositis
11:12
Part 2 Covid Vaccine in Autoiummune diseases
13:22
Covid Vaccine in Autoimmune Disease Part 1
05:01
How to evaluate your weakness yourself ? Do Sit to Stand at home using this Myositis101 video
03:25
Sit to Stand STS test training video
03:10
Timed and Go Test (TUG) training video
27:45
What is Myositis Autoantibody and it's role in Myositis
01:02:32
Managing Myositis During Covid
17:36
All you need to know about Masks in Covid 19
01:03:15
Webinar on Covid-19 related questions for myositis patients
11:24
Covid 19 and Immunosuppressive drugs
17:32
Covid 19
10:44
Muscle pain, Fatigue & Weakness - Myositis 101 for patients - 6th video
14:20
Diagnosis of Myositis - Myositis 101 for Patients_5
12:52
Triggers of Myositis - Myositis 101 for patients 4th video
07:19
Genetic risk of myositis - Myositis101 for patients - 3rd video
06:23
Who Gets Myositis: Myositis 101 for Patients 2nd video
12:26
What is Myositis? Myositis101 for patients
X
About
Myositis101 is a channel dedicated to myositis patients and family members. In this channel Dr. Rohit Aggarwal from Myositis Center of University of Pittsburgh, Chair of Medical Advisory Board of The Myositis Association (TMA) and author of the book "Managing Myositis: A Practical Gudie" explains in simple words to the patients and their family member about myositis. Each week Dr. Aggarwal post new topic on myositis covering various different aspects of myositis from symptoms to diagnosis to treatment.
Tags